Tigilanol Tiglate — FDA Animal & Veterinary Adverse Event (ADE) Reports
Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Tigilanol Tiglate is a active ingredient.
Total reports
Tigilanol Tiglate: 1998
Reports by species (top entries)
- Dog 1974
- Human 9
- Horse 5
- Cat 2
- Other 1
Top reported reactions (VEDDRA terms, top entries)
- Lack of efficacy - NOS 853
- Injection site swelling 688
- Wound 400
- Injection site pain 298
- Pain NOS 290
- Swelling NOS 285
- Injection site necrosis 233
- Swollen limb 223
- Injection site complication NOS 214
- Injection site bruising 206
Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b10.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).